Table of Contents

As filed with the Securities and Exchange Commission on May 27, 2014

Registration No. 333-            

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM S-3

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

AMEREN CORPORATION
(Exact name of registrant as specified in its charter)

Missouri
(State or other jurisdiction
of incorporation or organization)
  43-1723446
(IRS Employer
Identification No.)
1901 Chouteau Avenue
St. Louis, Missouri 63103
(314) 621-3222

(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
MARTIN J. LYONS, JR.
Executive Vice President and Chief Financial Officer
GREGORY L. NELSON
Senior Vice President, General Counsel and Secretary
1901 Chouteau Avenue
St. Louis, Missouri 63103
(314) 621-3222

(Names, address, including zip code, and telephone number,
including area code, of agent for service)

        Approximate date of commencement of proposed sale to the public:    From time to time after this registration statement becomes effective.

          If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box.    o

          If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box.    ý

          If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, please check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering. o

          If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box and list the Securities Act of 1933 registration statement number of the earlier effective registration statement for the same offering.    o

          If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.    ý

          If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.    o

          Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ý   Accelerated filer o   Non-accelerated filer o   Smaller reporting company o

CALCULATION OF REGISTRATION FEE

 

Title of
securities to be registered

  Amount to be
registered(1)

  Proposed maximum
offering price
per unit(2)

  Proposed maximum
aggregate offering
price(2)

  Amount of
registration fee(3)

 

Common Stock, $.01 par value

  8,624,426 shares   $38.525   $332,256,011.65   $38,577.94

 


(1)
In addition, pursuant to Rule 416(a) of the Securities Act of 1933, this registration statement also covers such indeterminable number of additional securities as may become deliverable as a result of stock splits, stock dividends, split-ups, recapitalizations or similar transactions, in accordance with the provisions of the Plan.

(2)
Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933 on the basis of the average of the high and low prices of the registrant's common stock on the New York Stock Exchange composite tape on May 20, 2014.

(3)
Pursuant to Rule 415(a)(6) under the Securities Act of 1933, 2,624,426 shares of Ameren Corporation's common stock registered hereunder are unsold securities previously registered on Registration Statement No. 333-175151 filed on June 27, 2011 (the "Prior Registration Statement"). Pursuant to Rule 415(a)(6) under the Securities Act of 1933, the $8,805.82 filing fee previously paid in connection with such unsold securities will continue to be applied to such unsold securities. The amount of the registration fee in the "Calculation of Registration Fee" table relates to the additional 6,000,000 shares of Ameren Corporation's common stock being registered hereunder. As a result, a filing fee of $29,772.12 is being paid herewith. Pursuant to Rule 415(a)(6) under the Securities Act of 1933, the offering of unsold securities under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this registration statement.


Table of Contents

PROSPECTUS                                                                                                      

LOGO


DRPlus

Dividend Reinvestment and Stock Purchase Plan

         Ameren Corporation has established its DRPlus Dividend Reinvestment and Stock Purchase Plan (Plan) to provide participants with a convenient way to purchase shares of our common stock and to reinvest all or a portion of the cash dividends paid on our common stock in additional shares of our common stock.

Participants in the Plan may:

         Shares of our common stock purchased under the Plan will, at our option, be newly-issued shares or treasury shares purchased directly from us, or shares purchased in the open market or in privately-negotiated transactions. Any open market or privately-negotiated purchases will be made through an independent agent selected by us. This prospectus relates to 8,624,426 shares of common stock offered under the Plan.

         If you are currently participating in the Plan, you will remain enrolled in the Plan, and you do not have to take any action unless you wish to terminate your participation or change your election in the Plan.

         Our common stock is listed on the New York Stock Exchange under the ticker symbol "AEE."

         To the extent required by applicable law in certain jurisdictions, shares of common stock offered under the Plan to certain persons are offered only through a registered broker/dealer in such jurisdictions.

         Our principal executive offices are located at 1901 Chouteau Avenue, St. Louis, Missouri 63103 and our telephone number is (314) 621-3222.

         Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

         Investing in our common stock involves risks. Before buying our common stock, you should refer to the risk factors included in our annual, quarterly and current reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, which are incorporated by reference into this prospectus, and in other information that we file with the Securities and Exchange Commission.


The date of this prospectus is May 27, 2014.


Table of Contents


AMEREN CORPORATION

        Ameren, headquartered in St. Louis, Missouri, is a public utility holding company under the Public Utility Holding Company Act of 2005, administered by the Federal Energy Regulatory Commission. Ameren's primary assets are its equity interests in its subsidiaries. Ameren's subsidiaries are separate, independent legal entities with separate businesses, assets, and liabilities. Dividends on Ameren's common stock and the payment of other expenses by Ameren depend on distributions made to it by its subsidiaries. Ameren's principal subsidiaries are listed below.

        Ameren has various other subsidiaries responsible for activities such as the provision of shared services. Ameren also has a subsidiary, Ameren Transmission Company of Illinois, that operates a FERC rate-regulated electric transmission business and is developing the Illinois Rivers project.

        In this prospectus, "Ameren," "we," "us" and "our" refer to Ameren Corporation and, unless the context otherwise indicates, do not include our subsidiaries.

2


Table of Contents


WHERE YOU CAN FIND MORE INFORMATION

        We have filed a registration statement on Form S-3 with the Securities and Exchange Commission (SEC) under the Securities Act of 1933. This prospectus is part of the registration statement, but the registration statement also contains or incorporates by reference additional information and exhibits. We are subject to the informational requirements of the Securities Exchange Act of 1934 and, therefore, we file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read a copy of the registration statement and any document that we file with the SEC at the SEC's public reference room at 100 F Street, N.E., Washington, D.C. 20549. You can call the SEC's toll-free telephone number at 1-800-SEC-0330 for further information on the public reference room. The SEC maintains a website at http://www.sec.gov that contains reports, proxy and information statements and other information regarding companies, such as us, that file documents with the SEC electronically. The documents can be found by searching the EDGAR archives of the SEC electronically.

        The SEC allows us to "incorporate by reference" the information that we file with the SEC which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus and you should read it with the same care. Later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference the following documents previously filed with the SEC:

        We are also incorporating by reference all additional documents that we file with the SEC under Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934 between the date of this prospectus and the time that all of the shares of common stock registered are sold.

        Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or in any separately filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes that statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute part of this prospectus.

3


Table of Contents

        You may request a free copy of these filings by writing or telephoning us at the following address:

        You should rely only on the information incorporated by reference or provided in this prospectus or any supplement. We have not authorized anyone else to provide you with different or additional information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these shares of common stock under the Plan in any jurisdiction where the offer or sale is not permitted. You should not assume that the information in this prospectus or any supplement is accurate as of any date other than the date on the front of those documents or that the information incorporated by reference is accurate as of any date other than the date of the document incorporated by reference. Our business, financial position, results of operations and prospects may have changed since those dates.

4


Table of Contents


DESCRIPTION OF THE PLAN

        The provisions of the Plan in effect on and after the date hereof are presented in the following questions and answers. If you are not a participant in the Plan, you will continue to receive cash dividends, as declared, in the usual manner.

Purpose

1.     What is the purpose of the Plan?

        The purpose of the Plan is to provide participants (see Question 8) with a convenient way to purchase our common stock and to reinvest all or a portion of the cash dividends paid on our common stock (Eligible Securities) in additional shares of our common stock. When shares of our common stock purchased under the Plan are acquired directly from us, we will receive additional equity funds which will be added to our general funds and used for general corporate purposes as described in "Use of Proceeds."

Advantages

2.     What are the advantages of the Plan?

5


Table of Contents

Disadvantages

3.     What are the disadvantages of the Plan?

        A participant will have no control over the prices at which shares are purchased or sold for his or her account, because:

Therefore, the participant will bear the risk of fluctuations in the market price of our common stock.

Other Features

4.     What are other features of the Plan?

Administration

5.     Who administers the Plan?

        Ameren Services Company, a wholly-owned subsidiary of Ameren, will administer the Plan through its Investor Services Department (Investor Services). Among other things, Ameren Services will receive and hold participants' funds pending investment in additional shares of common stock, effect transfers of common stock, keep a continuous record of participation and prepare and send to each participant statements of the participant's Plan account. The responsibilities of Ameren Services in connection with the administration of the Plan are administrative in nature and, in large part, are consistent with the responsibilities of Ameren Services in acting as our registered transfer agent.

        If we elect to meet the requirements of participants by purchasing shares of common stock in the open market or in privately-negotiated transactions, an independent agent will act on behalf of participants in buying such shares. An independent agent will also sell Plan shares on behalf of participants.

6


Table of Contents

        We reserve the right to interpret and administer the Plan as deemed necessary or desirable, including the right to limit or deny participation in the Plan where circumstances warrant. The terms and conditions of the Plan and its operation shall be governed by and construed in accordance with the laws of the State of Missouri. Ameren, Ameren Services, and any independent agent will not be liable for any act done in good faith or for any omission to act in good faith, provided that Ameren, Ameren Services and any independent agent shall not be relieved from any liability imposed under any federal, state or other applicable securities law which cannot be waived. We cannot assure you of a profit or protect you against a loss on shares purchased or sold under the Plan. A participant participates in the Plan at his or her sole discretion, risk and responsibility.

6.    Who should I contact with questions concerning the Plan and its administration?

        You may contact us with questions concerning the Plan

7.     May the Plan be suspended, modified or discontinued?

        We reserve the right to suspend, modify or discontinue the Plan at any time, including but not limited to the right to modify the fees and commissions charged to participants. We will announce any suspension, major modification or discontinuance of the Plan to all participants.

Eligibility

8.     Who is eligible to participate in the Plan?

        Any person of legal age or entity, whether or not a holder of Eligible Securities, is eligible to participate in the Plan provided that such person or entity fulfills the prerequisites for participation described under Question 9 and participation would not violate the securities or other laws of the state, territory or country where the participant resides that are applicable to Ameren, the Plan or the participant.

        A Plan prospectus and enrollment or application information will be furnished upon request made to Investor Services or it may be obtained from our website at http://www.ameren.com/investors.

7


Table of Contents

Participation

9.     How do I enroll in the Plan or change my method of participation?

        After receiving a copy of this prospectus, eligible applicants may become participants in the Plan by completing and signing an enrollment form (shareholders) or an application (non-shareholders). The minimum initial optional cash investment is $25 for shareholders and $250 for non-shareholders. The maximum aggregate optional cash investment that may be made by a participant in any calendar year is $360,000.

        The enrollment form and application each require a participant to choose a reinvestment option for participation in the Plan. By checking the appropriate box, a participant may select:

        Eligible Securities include shares held through our direct registration system. These are shares registered directly on our books without physical certificates. The direct registration system is managed by The Depository Trust & Clearing Corporation and enables its participants to electronically move securities between street-name ownership and our books. See Question 26.

        Participants may change their reinvestment options by completing the correspondence portion of their statement of account or an enrollment form and sending it to Investor Services. Changes will become effective as soon as practicable after they are received. Any change in reinvestment options must be received by the dividend record date in order to be effective on the related dividend payment date.

10.   How does an Employee participate?

        An Employee may join the Plan at any time by enrolling in the same manner as any other eligible person described under Question 9 or by completing a Payroll Deduction Authorization form.

8


Table of Contents

Dividend Reinvestment

11.   How and when will cash dividends be reinvested?

        If a participant has elected full or partial dividend reinvestment on the Eligible Securities registered in the participant's name and/or the participant's Plan shares, we will reinvest those dividends in additional shares of our common stock. With respect to partial dividend reinvestment, a minimum of 10% per share with respect to shares held in a participant's Plan account must be reinvested and the remaining dividends are paid in cash. No minimum reinvestment per share is required on shares held outside of a participant's Plan account in either certificated form or through our direct registration system and registered in the name of the participant. The source of common stock to be purchased under the Plan may be, at our discretion, authorized but unissued or treasury shares of common stock or shares of common stock purchased in the open market or in privately-negotiated transactions by an independent agent.

        If we are meeting the requirements of the Plan with common stock purchased in the open market or in privately-negotiated transactions, an independent agent will determine the exact timing of such purchases and the number of shares to be purchased, depending on the amount of reinvested dividends, market conditions and the requirements of the federal securities laws, and the purchased shares will be credited to a participant's Plan account as of the applicable Investment Date, as defined below. If we elect to issue authorized but unissued or treasury shares of our common stock, these shares will be issued by us and credited to a participant's Plan account as of the applicable Investment Date. The determination of the price for purchases of Plan shares is explained in Question 18.

        If a participant's enrollment form is received by Investor Services on or before the record date with respect to any common stock cash dividend payment date, then the dividend payable on such payment date will be used to purchase additional shares of common stock as of such payment date (an Investment Date). If the enrollment form is received after the record date for any such cash dividend payment date, the reinvestment of dividends will start with the next dividend payment date.

        Common stock cash dividend payment dates are normally on or about the last business day of March, June, September and December. You should contact Investor Services for more information with respect to dividend payment dates.

        Although the Plan provides for the reinvestment of common stock dividends, the amount and timing of dividends payable on our common stock are within the sole discretion of our board of directors. The board of directors has not set specific targets or payout parameters when declaring common stock dividends. However, as it has done in the past, the board of directors is expected to consider various issues, including our overall payout ratio, payout ratios of our peers, projected cash flow and potential future cash flow requirements, historical earnings and cash flow, projected earnings, impacts of regulatory orders or legislation, and other key business considerations.

9


Table of Contents

Optional Cash Investments

12.   Who is eligible to make optional cash investments?

        All Plan participants are eligible to make optional cash investments.

13.   How are optional cash investments made?

        A Plan participant may make an initial cash investment when enrolling by enclosing a check with the enrollment form or application. Checks should be made payable to "Ameren Corporation," and returned in the envelope provided with the enrollment form or application. Thereafter, optional cash investments may be made by using the cash investment form attached to the statement of account, by Automatic Cash Investment (see Question 14) or by Employee payroll deduction (see Question 10). Please contact Investor Services for additional cash investment forms.

14.   What is the Automatic Cash Investment option of the Plan and how does it work?

        The Automatic Cash Investment option offers participants in the Plan a direct debit service. Optional cash investments are electronically withdrawn from your personal checking or savings account at least once a month, usually near the end of the month, and used to purchase common stock. The direct debit from your personal bank account will be shown on the monthly statement from your financial institution. In addition, you will receive a statement from Investor Services detailing the cash received and shares purchased.

        The Automatic Cash Investment option may be authorized for regular monthly amounts from $25 to $30,000. Funds authorized for investment through the Automatic Cash Investment option will be debited approximately four business days prior to the applicable optional cash investment date. See Question 16.

        For an Automatic Cash Investment application, please contact Investor Services.

15.   What are the limitations on making optional cash investments?

        Optional cash investments cannot be less than $25 per investment ($250 in the case of the initial optional cash investment by a non-shareholder). The maximum aggregate optional cash investment that may be made by a participant in any calendar year cannot exceed $360,000.

16.   When will optional cash investments be invested?

        The option to make cash investments is available to you at any time. Unless otherwise notified by us, there will be an optional cash investment date on the 15th, or the prior business day if the 15th is not a business day, and the last business day of each month. In any event, purchases on behalf of Plan participants will be made at least once a month. Participants will receive a notice at the beginning of each year specifying the optional cash investment dates for such year. Purchases may be made by the

10


Table of Contents

independent agent over a period of several days in the case of market purchases. All such purchases will be aggregated and credited to participants' accounts on the optional cash investment date occurring on or after receipt of the optional cash investment.

        Cash received after an optional cash investment date will be invested as of the next optional cash investment date. No interest will be paid by us on any cash investments received by us pending investment.

Purchases

17.   How many shares of common stock will be purchased?

        The number of shares purchased for you under the Plan depends on what you have authorized in regard to dividend reinvestment, plus any optional cash investments made, and the price at which the shares are purchased by the Plan. With respect to Full Dividend Reinvestment, your available funds will be fully invested in both whole and fractional shares of common stock (computed to four decimal places). With respect to Partial Dividend Reinvestment, a minimum of 10% per share with respect to shares held in a participant's Plan account must be reinvested and the remaining dividends would be paid in cash. No minimum reinvestment per share is required on shares held outside of a participant's Plan account in either certificated form or through our direct registration system. No one can predict the number of shares that will be purchased for you during a particular purchase period, and you cannot direct the purchase of a specific number of shares.

18.   What is the price of shares purchased for the Plan?

        If shares for the Plan are being purchased in the open market or in privately-negotiated transactions, the price of such shares will be the weighted average price at which the independent agent acquired the shares plus applicable brokerage commissions and other fees. If the shares are purchased directly from us, the price of such shares will be the average of the high and low sale prices of our common stock on the applicable Investment Date as reported on the Consolidated Tape System for New York Stock Exchange listed companies administered by the Consolidated Tape Association.

19.   Who purchases the shares for the Plan?

        If we elect to purchase shares of common stock in the open market or in privately-negotiated transactions, an independent agent will make all such purchases necessary to meet the requirements of the Plan. We do not exercise any direct or indirect control over the timing or price of purchases made by an independent agent. If open market or privately-negotiated purchases are not made, the shares purchased under the Plan will come directly from our authorized and unissued shares of common stock or from our treasury shares.

11


Table of Contents

        Purchases of common stock under the Plan will not be offset against sales of common stock under the Plan. See Question 21.

20.   Are any fees or expenses incurred by participants?

        We will pay the costs of administering the Plan, but participants will be required to pay brokerage commissions and other fees for shares purchased in the open market or in privately-negotiated transactions and shares sold through the Plan as well as any transfer tax, if applicable. Brokerage commissions will be at a negotiated rate established under the terms of our agreements with independent agents. See Question 7.

Sales and Termination from the Plan

21.   May participants sell or withdraw all or a portion of their shares from the Plan?

        Yes. Any participant may withdraw from the Plan, request that the Plan shares be moved into our direct registration system or that a certificate be issued for Plan shares, or request that Plan shares be sold and the cash proceeds forwarded to the participant. Participation in the Plan is entirely voluntary. Participants may sell or withdraw all or a portion of their shares by filling out the correspondence portion of their account statement or by contacting Investor Services.

        A stock certificate for any whole number of shares will be issued from your Plan account as soon as practicable after requested. If you would like stock certificates issued in a registration other than the name on your account, contact Investor Services.

        Investor Services will aggregate Plan sale requests and place a market order with an independent agent to sell such shares at least four times a month. The participant will receive the proceeds of the sale less any brokerage commission and any other fees as soon as practicable after the settlement date for the applicable sale. Participants' sales of shares of common stock under the Plan will not be offset against purchases of common stock under the Plan. Neither Investor Services nor the participant will have any authority to direct the time or price, designate the market or select the broker or dealer for the sale of such shares. See Question 19.

        If a participant's request for a sale or withdrawal is received by Investor Services on or after a dividend payment date, such request will be processed as soon as practicable after reinvested dividends have been allocated.

        If a participant's Plan account contains less than one full share, Investor Services reserves the right to sell any fractional share remaining in the account, forward the proceeds of the sale to the participant and terminate the account.

12


Table of Contents

Transfer of Shares Held in the Plan

22.   Can shares in the Plan be transferred?

        Upon written request, shares in the Plan can be transferred into names other than the account name, subject to compliance with any applicable laws and the payment by the participant of any applicable taxes, provided that the request is accompanied by a duly executed stock power that bears the signature(s) of the participant(s) and the signature(s) is/are Medallion Signature Guaranteed by a financial institution, such as a commercial bank or a brokerage firm, that is a member of either the STAMP, SEMP or MSP Medallion Signature Guarantee programs. Unless instructed otherwise, Ameren Services will move the transferred shares to an account in the transferee's name in the Plan and apply the same dividend reinvestment options as existed with respect to the transferred account.

Reports to Participants

23.   How will participants be advised of their purchase of shares of common stock and other activity in their Plan accounts?

        Participants will receive a quarterly statement as soon as practicable following the end of each calendar quarter. The last quarterly statement of each calendar year will reflect year-to-date Plan activity. In addition, a statement will be provided in any month an account has Plan activity. These statements are participants' continuing record of their Plan transactions and should be retained for tax purposes. Participants should be aware that it is important to retain all statements received as there may be a fee incurred to provide historical statement information.

        Participants will receive copies of the same communications sent to other registered shareholders of common stock, including our annual report, notice of annual meeting and proxy statement, and certain tax information.

Certificates

24.   Will stock certificates automatically be issued for shares of common stock acquired under the Plan?

        No. Unless you request otherwise as described below, the number of shares credited to your Plan account will be held by Ameren Services, as agent, and will be shown on your statement of account. This service protects against loss, theft or destruction of stock certificates.

        A certificate for any number of whole shares up to the full number of shares credited to your Plan account will be issued to you if you so request in writing. See Question 21. Such request should be mailed to Investor Services.

13


Table of Contents

        Shares credited to your Plan account may not be used as collateral. If you wish to use your Plan shares as collateral, you must request that a certificate be issued in your name. A certificate for fractional shares will not be issued under any circumstances.

Safekeeping Service for Common Stock Certificates

25.   What is the Plan's safekeeping service and how does it work?

        The Plan's safekeeping service allows you to deposit your common stock certificate(s) into your Plan account. The benefits of this service include the convenience of keeping all of your shares in one place, and the protection against the cost of replacing your certificates should they be lost, stolen or destroyed. If you would like to take advantage of this service, please contact Investor Services. Once the common stock certificate(s) is placed in safekeeping, the dividends paid on the common stock will be subject to a 10% minimum per share reinvestment.

Direct Registration System (DRS)

26.   What is the Direct Registration System?

        Shares held through the direct registration system (DRS) can be registered directly on our books without physical certificates. Participants in the Plan may choose to have their direct registration/book-entry shares electronically delivered to or from their brokerage accounts.

        You may move at any time, free of charge, all or a part of the whole Plan shares of our common stock credited to your account to DRS upon written request to Investor Services. The movement of Plan shares into DRS will not change your reinvestment instructions unless you direct otherwise. No fractional shares of our common stock may be held in DRS under any circumstances.

        If the shares in DRS are to be issued in a name other than the name(s) reflected on your Plan account, the signature on the instructions or stock power must be guaranteed by a financial institution participating in the Medallion Signature Guarantee program. See Question 22.

Online Services

27.   What transactions can a participant conduct through our website?

        Through our website, a participant may:

14


Table of Contents

        and a participant may:

        Participation in the Plan through our online services is voluntary. A participant can access such services at our website at http://www.ameren.com/investors.

Income Taxes

28.   What are the federal income tax consequences of participation in the Plan?

        In general, participants in the Plan have the same federal income tax obligations with respect to their dividends as do shareholders who are not Plan participants. This means that dividends reinvested under the Plan are taxable as having been received even though the participants did not actually receive them in cash but, instead, used them to purchase additional shares under the Plan.

        With respect to reinvested cash dividends on our common stock used to purchase authorized but unissued shares from us, a participant will be treated for federal income tax purposes as having received a distribution in an amount equal to the fair market value on the dividend payment date of the full number of shares and fractional shares purchased with reinvested dividends. The fair market value of such shares on the dividend payment date will be treated as dividend income to the participant to the extent of our current and accumulated earnings and profits, as determined for federal income tax purposes. The basis of the shares so purchased will be equal to the fair market value of such shares on the dividend payment date.

        With respect to reinvested cash dividends on our common stock used to purchase shares in the open market or through negotiated transactions, a participant will be treated for federal income tax purposes as having received a distribution in an amount equal to the cash reinvested to obtain the shares. The cash reinvested will be treated as dividend income to the participant to the extent of the current and accumulated earnings and profits of the distributing entity, as determined for federal income tax purposes. The basis of the shares so purchased will be equal to the amount of this distribution, plus the amount of any brokerage commissions and other fees paid by the participant.

        In the case of either the issuance of shares by us or the purchase of shares in the open market, if the amount of a distribution is in excess of our earnings and profits, such excess will not be treated as dividend income, but instead, a return of capital to you. In the event of a return of capital distribution, we will provide you with reports indicating the amount of the return of capital. You must reduce the tax basis of the stock on which the distribution is paid by the amount of the distribution that is a return of capital.

15


Table of Contents

To the extent any return of capital distribution exceeds your tax basis in your stock, the excess must be reported as capital gains.

        Dividends paid are eligible for a reduced rate of federal income taxation for individuals of up to 20% (plus the 3.8% Medicare tax described below, if applicable), provided that the dividend is paid with respect to shares held for more than 60 days during the 121-day period beginning 60 days before the ex-dividend date, the individual is not obligated to make related payments with respect to substantially similar or related property, and certain other conditions are met.

        U.S. individuals, trusts and estates having adjusted gross income in excess of $200,000 ($250,000 in the case of married, filing jointly) will be subject to a 3.8% Medicare tax on investment earnings, including dividends and gains received or recognized with respect to our stock.

        A participant who purchases shares with optional cash payments will recognize no taxable income upon such purchases. The tax basis of shares purchased in this manner will be the amount of the optional cash investment.

        A participant does not realize any taxable income when he receives certificates for whole shares of common stock credited to his account under the Plan, either upon request for certificates for those shares, termination of his participation in the Plan, or termination of the Plan by us. However, the sale of shares by a participant under the Plan may give rise to a capital gain or loss, provided such shares are held as a capital asset by the participant. Any such gain or loss will be measured by the difference between the proceeds received by the participant (net of commissions and fees) and the participant's tax basis in the shares sold. Such gain or loss will generally be long-term capital gain or loss if the participant held the shares for more than one year immediately prior to such disposition. Long-term capital gains of noncorporate taxpayers (i.e., individuals, trusts and estates) are taxed at a maximum of 20% (plus the 3.8% Medicare tax described above, if applicable). The deductibility of capital losses is subject to limitations. The holding period for shares acquired under the Plan begins on the day after the shares are credited to a participant's Plan account.

        When you sell shares held in your Plan account which are acquired after 2011, we will be required to report to you and the Internal Revenue Service the basis and holding period of those shares on IRS Form 1099-B. We have adopted the first-in, first-out (FIFO) method as our default method for these shares and will report the sale of these shares to you and the Internal Revenue Service under this method unless you notify us that you are electing to use some other acceptable basis to identify the stock sold. If you would like to use a method other than FIFO for such shares, you will need to contact Investor Services to make a written election for the methodology to apply to your shares held in the Plan. Once you sell your shares, the method used to calculate your adjusted basis and any gains or losses with respect to such shares cannot be changed. Therefore, it is important to consider the tax implications before you request a sale.

16


Table of Contents

        For participants who are subject to U.S. withholding tax, backup withholding or foreign taxes, we will withhold the required taxes from the gross dividends or proceeds from the sale of shares. The dividends or proceeds received by the participant, or dividends reinvested on behalf of the participant, will be net of the required taxes. Such withholding taxes may be reduced or eliminated by treaty between the U.S. and the country in which the participant resides, if the participant provides appropriate documentation to claim the benefit of the treaty. However, notwithstanding any reduced or eliminated withholding taxes on dividends pursuant to such a treaty, a U.S. withholding tax at a 30% tax rate will be imposed on dividends paid on or after July 1, 2014, and on proceeds of sales paid on or after January 1, 2017, to foreign shareholders if certain disclosure requirements are not satisfied.

        The information explained above is only a summary and does not purport to be a complete description of all tax consequences of participation in the Plan. The description may be affected by future legislation, Internal Revenue Service rulings and regulations, or court decisions. In addition, the taxation of foreign shareholders, except as noted, is not discussed in this prospectus. Accordingly, you should consult your own tax advisors with respect to the federal, state, local and foreign tax consequences of your participation in the Plan.

17


Table of Contents


DESCRIPTION OF COMMON STOCK

General

        The following statements describing the Company's common stock are not intended to be a complete description but rather are a summary of certain rights and distinguishing characteristics relating to the common stock currently authorized by the Company's Restated Articles of Incorporation, as amended ("articles of incorporation"). For additional information, please see the Company's articles of incorporation and by-laws. Each of these documents has been previously filed with the SEC and each is an exhibit to this registration statement. Reference is also made to the laws of the state of Missouri.

        Under our articles of incorporation, we are authorized to issue 400 million shares of common stock, $.01 par value per share, and 100 million shares of preferred stock, $.01 par value per share. As of April 30, 2014, approximately 242,634,798 shares of common stock and no shares of preferred stock were outstanding.

Dividend Rights and Limitations

        The holders of our common stock are entitled to receive such dividends as our board of directors may from time to time declare, subject to any rights of the holders of our preferred stock, if any is issued. Our ability to pay dividends depends primarily upon the ability of our subsidiaries to pay dividends or otherwise transfer funds to us. Various financing arrangements, charter provisions and statutory and regulatory requirements may impose certain restrictions on the ability of our subsidiaries to transfer funds to us in the form of cash dividends, loans or advances.

Voting Rights

        Except as otherwise provided by law and subject to the voting rights of holders of our preferred stock, if any is issued, the holders of our common stock have the exclusive right to vote for the election of directors and for all other purposes. Each holder of our common stock is entitled to one vote per share on all matters submitted to a vote at a meeting of shareholders, including the election of directors, which means that the holders of more than 50% of the shares voting for the election of directors can elect 100% of the directors and the holders of the remaining shares voting for the election of directors will not be able to elect any directors. The common stock shall vote together as a single class. The holders of our common stock are not entitled to cumulate votes for the election of directors. At annual and special meetings of shareholders, a majority of the outstanding shares of common stock constitutes a quorum.

Liquidation Rights

        In the event of any liquidation, dissolution or winding up of our affairs, voluntarily or involuntarily, the holders of our common stock will be entitled to receive the remainder, if any, of our assets after the

18


Table of Contents

payment of all our debts and liabilities and after the payment in full of any preferential amounts to which holders of any preferred stock may be entitled.

Uncertificated Shares and Certificates of Stock

        The interest of each shareholder of any class of our stock shall not be evidenced by certificates for shares and all shares of all classes of stock shall be uncertificated shares; provided, however, that (a) any shares of our stock represented by a certificate shall continue to be represented by such certificate until such certificate is surrendered to us and (b) we may, at our option but without obligation, issue certificates for some or all of any shares of some or all of any classes of stock as we determine from time to time.

Miscellaneous

        The outstanding shares of common stock are, and the shares of common stock sold hereunder will be, upon payment for them, fully paid and nonassessable. The holders of our common stock are not entitled to any preemptive or preferential rights to subscribe for or purchase any part of any new or additional issue of stock or securities convertible into stock. Our common stock does not contain any redemption provisions or conversion rights.

Transfer Agent and Registrar

        Ameren Services Company, a subsidiary of Ameren, acts as transfer agent and registrar for the common stock.

Certain Anti-Takeover Matters

        Our restated articles of incorporation and by-laws include a number of provisions that may have the effect of discouraging persons from acquiring large blocks of our stock or delaying or preventing a change in our control. The material provisions that may have such an effect include:

19


Table of Contents

        In addition, the Missouri General and Business Corporation Law, or the MGBCL, contains certain provisions, including control share acquisition provisions and business combination provisions that would be applicable to certain mergers, share exchanges or sales of substantially all assets involving us or a subsidiary and a significant shareholder and which could have the effect of substantially increasing the cost to the acquiror and thus discouraging any such transaction. The MGBCL permits shareholders to adopt an amendment to the articles of incorporation opting out of the control share acquisition provisions, and our restated articles of incorporation opt out of such provisions.

        Under the Illinois Public Utilities Act, approval of the Illinois Commerce Commission is required for any transaction which, regardless of the means by which it is accomplished, results in a change in the ownership of a majority of the voting capital stock of an Illinois public utility or the ownership or control of any entity which owns or controls a majority of the voting capital stock of a public utility. Because we control a majority of the voting stock of Ameren Illinois Company, a public utility subject to Illinois utility regulation, any change in our ownership or control, within the meaning of the Illinois Public Utilities Act, would require Illinois Commerce Commission approval. Certain acquisitions by any person of our outstanding voting shares would also require approval under the Federal Power Act and the Atomic Energy Act of 1954, as amended.


USE OF PROCEEDS

        The number of shares of common stock, if any, that we will sell under the Plan and the prices at which such shares will be sold cannot presently be determined. The number and prices of shares sold will be affected by the level of participation in the Plan, the prevailing prices of our common stock and whether the shares are newly-issued or treasury shares or shares purchased in the open market or privately-negotiated transactions. If newly-issued or treasury shares of common stock are sold by us under the Plan, we will use the net proceeds we receive from the sale:

        If shares are purchased by an independent agent in the open market or in privately-negotiated transactions for sale under the Plan, we will not receive any proceeds from such sales.

20


Table of Contents


LEGAL MATTERS

        Gregory L. Nelson, Esq., Senior Vice President, General Counsel and Secretary of Ameren Corporation, has issued a legal opinion as to certain legal matters in connection with the common stock offered by this prospectus. As of May 19, 2014, Mr. Nelson owned 19,215 shares of Ameren's common stock. In addition, as of that date, Mr. Nelson owned 67,945 performance share units, none of which are fully vested.


EXPERTS

        The financial statements of Ameren Corporation as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013 and management's assessment of the effectiveness of internal control over financial reporting (which is included in Management's Report on Internal Control Over Financial Reporting) as of December 31, 2013 incorporated in this prospectus by reference to the Annual Report on Form 10-K of Ameren Corporation for the year ended December 31, 2013, have been so incorporated in this prospectus in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

21


Table of Contents


        No dealer, salesperson or other person is authorized to give any information to or represent anything not contained in this prospectus. You must not rely on any unauthorized information or representations. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus is current only as of its date.



TABLE OF CONTENTS

 
  Page  
Ameren Corporation     2  
Where You Can Find More Information     3  
Description of the Plan     5  
Description of Common Stock     18  
Use of Proceeds     20  
Legal Matters     21  
Experts     21  

Ameren Corporation

DRPlus
Dividend Reinvestment
and Stock Purchase Plan

Common Stock


PROSPECTUS
May 27, 2014



Table of Contents


PART II. INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.    Other Expenses of Issuance and Distribution

Securities and Exchange Commission registration fee

  $ 38,577.94 *

Stock exchange listing fees

    22,500.00  

Printing expenses

    17,000.00  

Fees of accountants

    5,000.00  

Fees of attorneys

    25,000.00  

Miscellaneous expenses

    6,922.06  
       

Total

  $ 115,000.00  
       
       

*
Actual expenses; all other expenses are estimates.

Item 15.    Indemnification of Directors and Officers

        Article IV of Ameren's by-laws, consistent with the applicable provisions of the MGBCL, provides for indemnification of directors and officers. Article IV provides as follows:

II-1


Table of Contents

II-2


Table of Contents

II-3


Table of Contents

        Consistent with the applicable provisions of the MGBCL and the by-laws, the Company has purchased insurance on behalf of its officers and directors which insures them against certain liabilities and expenses, including those under the Securities Act of 1933, as amended.

II-4


Table of Contents


Item 16.    Exhibits

Exhibit
No.
  Description
  *4.1   Restated Articles of Incorporation of Ameren (Annex F to Part I of the Registration Statement on Form S-4, File No. 33-64165).

 

*4.2

 

Certificate of Amendment to Ameren's Restated Articles of Incorporation filed December 14, 1998 (1998 Form 10-K, Exhibit 3(i), File No. 1-14756).

 

*4.3

 

Certificate of Amendment to Ameren's Restated Articles of Incorporation filed April 21, 2011 (April 21, 2011 Form 8-K, Exhibit 3(i), File No. 1-14756).

 

*4.4

 

Certificate of Amendment to Ameren's Restated Articles of Incorporation filed December 18, 2012 (December 18, 2012 Form 8-K, Exhibit 3.1(i), File No. 1-14756).

 

*4.5

 

By-Laws of Ameren, as amended December 14, 2012 (December 18, 2012 Form 8-K, Exhibit 3.1(ii), File No. 1-14756).

 

  5

 

Opinion of Gregory L. Nelson, Esq., Senior Vice President, General Counsel and Secretary of Ameren, regarding the validity of the securities.

 

23.1

 

Consent of Gregory L. Nelson, Esq., Senior Vice President, General Counsel and Secretary of Ameren (included in Exhibit 5).

 

23.2

 

Consent of independent registered public accounting firm.

 

24

 

Power of Attorney.

Note:   Reports of the Company on Forms 8-K, 10-Q and 10-K are on file with the Securities and Exchange Commission under file number 1-14756.

*
Incorporated by reference herein as indicated.


Item 17.    Undertakings

        a.     The undersigned registrant hereby undertakes:

II-5


Table of Contents

II-6


Table of Contents

        b.     Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described under Item 15 above, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.

II-7


Table of Contents


SIGNATURES

        Pursuant to the requirements of the Securities Act of 1933, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of St. Louis, State of Missouri, on the 27th day of May, 2014.

    AMEREN CORPORATION (REGISTRANT)

 

 

By:

 

/s/ WARNER L. BAXTER

Warner L. Baxter
President and Chief Executive Officer

        Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

Name
 
Title
 
Date

 

 

 

 

 
/s/ WARNER L. BAXTER

Warner L. Baxter
  President and Chief Executive Officer and Director (Principal Executive Officer)   May 27, 2014

/s/ MARTIN J. LYONS, JR.

Martin J. Lyons, Jr.

 

Executive Vice President and Chief Financial Officer (Principal Financial Officer)

 

May 27, 2014

/s/ BRUCE A. STEINKE

Bruce A. Steinke

 

Senior Vice President, Finance and Chief Accounting Officer (Principal Accounting Officer)

 

May 27, 2014

*

Catherine S. Brune

 

Director

 

May 27, 2014

*

Ellen M. Fitzsimmons

 

Director

 

May 27, 2014

*

Walter J. Galvin

 

Director

 

May 27, 2014

*

Richard J. Harshman

 

Director

 

May 27, 2014

*

Gayle P. W. Jackson

 

Director

 

May 27, 2014

*

James C. Johnson

 

Director

 

May 27, 2014

Table of Contents

Name
 
Title
 
Date

 

 

 

 

 
*

Steven H. Lipstein
  Director   May 27, 2014

*

Patrick T. Stokes

 

Director

 

May 27, 2014

*

Thomas R. Voss

 

Director

 

May 27, 2014

*

Stephen R. Wilson

 

Director

 

May 27, 2014

*

Jack D. Woodard

 

Director

 

May 27, 2014

*By:

 

/s/ MARTIN J. LYONS, JR.


Martin J. Lyons, Jr.
Attorney-in-Fact
 

 

 

 


Table of Contents


EXHIBIT INDEX

Exhibit
No.
  Description
  5   Opinion of Gregory L. Nelson, Esq., Senior Vice President, General Counsel and Secretary of Ameren, regarding the validity of the securities.

 

23.1

 

Consent of Gregory L. Nelson, Esq., Senior Vice President, General Counsel and Secretary of Ameren (included in Exhibit 5).

 

23.2

 

Consent of independent registered public accounting firm.

 

24

 

Power of Attorney.